| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3880798
[patent_doc_number] => 05798229
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-25
[patent_title] => 'Bispecific molecules recognizing lymphocyte antigen CD2 and tumor antigens'
[patent_app_type] => 1
[patent_app_number] => 8/284947
[patent_app_country] => US
[patent_app_date] => 1994-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 6539
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/798/05798229.pdf
[firstpage_image] =>[orig_patent_app_number] => 284947
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/284947 | Bispecific molecules recognizing lymphocyte antigen CD2 and tumor antigens | Aug 1, 1994 | Issued |
Array
(
[id] => 3663876
[patent_doc_number] => 05625038
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-29
[patent_title] => 'Monoclonal antibodies specific for Erysipelothrix rhusiopathiae'
[patent_app_type] => 1
[patent_app_number] => 8/281220
[patent_app_country] => US
[patent_app_date] => 1994-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7088
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/625/05625038.pdf
[firstpage_image] =>[orig_patent_app_number] => 281220
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/281220 | Monoclonal antibodies specific for Erysipelothrix rhusiopathiae | Jul 26, 1994 | Issued |
Array
(
[id] => 3597374
[patent_doc_number] => 05559012
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-24
[patent_title] => 'Therapeutic, IL-6 antibody kits, and process for their preparation'
[patent_app_type] => 1
[patent_app_number] => 8/280230
[patent_app_country] => US
[patent_app_date] => 1994-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 7823
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/559/05559012.pdf
[firstpage_image] =>[orig_patent_app_number] => 280230
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/280230 | Therapeutic, IL-6 antibody kits, and process for their preparation | Jul 24, 1994 | Issued |
Array
(
[id] => 3878842
[patent_doc_number] => 05798100
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-25
[patent_title] => 'Multi-stage cascade boosting vaccine'
[patent_app_type] => 1
[patent_app_number] => 8/268129
[patent_app_country] => US
[patent_app_date] => 1994-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10108
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/798/05798100.pdf
[firstpage_image] =>[orig_patent_app_number] => 268129
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/268129 | Multi-stage cascade boosting vaccine | Jul 5, 1994 | Issued |
Array
(
[id] => 3564478
[patent_doc_number] => 05484591
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-01-16
[patent_title] => 'Method for treating gram negative bacterial infections in humans'
[patent_app_type] => 1
[patent_app_number] => 8/277934
[patent_app_country] => US
[patent_app_date] => 1994-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17345
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/484/05484591.pdf
[firstpage_image] =>[orig_patent_app_number] => 277934
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/277934 | Method for treating gram negative bacterial infections in humans | Jun 30, 1994 | Issued |
Array
(
[id] => 3736286
[patent_doc_number] => 05785966
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-28
[patent_title] => 'Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients'
[patent_app_type] => 1
[patent_app_number] => 8/261905
[patent_app_country] => US
[patent_app_date] => 1994-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 5318
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/785/05785966.pdf
[firstpage_image] =>[orig_patent_app_number] => 261905
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/261905 | Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients | Jun 14, 1994 | Issued |
Array
(
[id] => 3820631
[patent_doc_number] => 05730975
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-24
[patent_title] => 'Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function'
[patent_app_type] => 1
[patent_app_number] => 8/255458
[patent_app_country] => US
[patent_app_date] => 1994-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 5761
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/730/05730975.pdf
[firstpage_image] =>[orig_patent_app_number] => 255458
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/255458 | Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function | Jun 7, 1994 | Issued |
| 08/249182 | AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY | May 24, 1994 | Abandoned |
Array
(
[id] => 4056015
[patent_doc_number] => 05863758
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-26
[patent_title] => 'Nucleic acids encoding osteogenic proteins'
[patent_app_type] => 1
[patent_app_number] => 8/449700
[patent_app_country] => US
[patent_app_date] => 1994-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 80
[patent_no_of_words] => 36593
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/863/05863758.pdf
[firstpage_image] =>[orig_patent_app_number] => 449700
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/449700 | Nucleic acids encoding osteogenic proteins | May 22, 1994 | Issued |
| 08/246929 | USE OF ANTI-TNF TO TREAT BACTERIAL MENINGITIS | May 19, 1994 | Abandoned |
| 08/243055 | HYBRIDOMA CELL LINES AND THEIR MONOCLONAL ANTIBODIES TO HUMAN PLURIPOTENT G-CSF | May 15, 1994 | Abandoned |
Array
(
[id] => 3657066
[patent_doc_number] => 05648078
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-15
[patent_title] => 'Method for inhibiting metastasis of colon cancer to the liver'
[patent_app_type] => 1
[patent_app_number] => 8/129195
[patent_app_country] => US
[patent_app_date] => 1994-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4247
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/648/05648078.pdf
[firstpage_image] =>[orig_patent_app_number] => 129195
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/129195 | Method for inhibiting metastasis of colon cancer to the liver | May 10, 1994 | Issued |
Array
(
[id] => 3696861
[patent_doc_number] => 05645834
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-08
[patent_title] => 'Method and product for treating failure of passive transfer and improving milk production in bovine species'
[patent_app_type] => 1
[patent_app_number] => 8/239886
[patent_app_country] => US
[patent_app_date] => 1994-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5939
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/645/05645834.pdf
[firstpage_image] =>[orig_patent_app_number] => 239886
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/239886 | Method and product for treating failure of passive transfer and improving milk production in bovine species | May 8, 1994 | Issued |
Array
(
[id] => 3635900
[patent_doc_number] => 05610281
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-11
[patent_title] => 'Antibodies for modulating heterotypic E-cadherin interactions with human T lymphocytes'
[patent_app_type] => 1
[patent_app_number] => 8/237919
[patent_app_country] => US
[patent_app_date] => 1994-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22031
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/610/05610281.pdf
[firstpage_image] =>[orig_patent_app_number] => 237919
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/237919 | Antibodies for modulating heterotypic E-cadherin interactions with human T lymphocytes | May 2, 1994 | Issued |
Array
(
[id] => 3655343
[patent_doc_number] => 05622835
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-22
[patent_title] => 'WT1 monoclonal antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/234783
[patent_app_country] => US
[patent_app_date] => 1994-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 3
[patent_no_of_words] => 9916
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/622/05622835.pdf
[firstpage_image] =>[orig_patent_app_number] => 234783
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/234783 | WT1 monoclonal antibodies | Apr 27, 1994 | Issued |
Array
(
[id] => 3525945
[patent_doc_number] => 05582826
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-10
[patent_title] => 'Monoclonal antibodies which bind the gamma chain of human interleukin-2 receptor'
[patent_app_type] => 1
[patent_app_number] => 8/230843
[patent_app_country] => US
[patent_app_date] => 1994-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 13878
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/582/05582826.pdf
[firstpage_image] =>[orig_patent_app_number] => 230843
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/230843 | Monoclonal antibodies which bind the gamma chain of human interleukin-2 receptor | Apr 20, 1994 | Issued |
| 08/226297 | BORRELIA BURGDORFERI BACTERIN | Apr 10, 1994 | Abandoned |
Array
(
[id] => 3495562
[patent_doc_number] => 05532159
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-02
[patent_title] => 'Monoclonal antibody to canine placental oncofetal protein for detecting cancer'
[patent_app_type] => 1
[patent_app_number] => 8/222201
[patent_app_country] => US
[patent_app_date] => 1994-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12106
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/532/05532159.pdf
[firstpage_image] =>[orig_patent_app_number] => 222201
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/222201 | Monoclonal antibody to canine placental oncofetal protein for detecting cancer | Mar 31, 1994 | Issued |
Array
(
[id] => 3574074
[patent_doc_number] => 05523229
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-04
[patent_title] => 'Antibodies specific for oncofetal fibronectin'
[patent_app_type] => 1
[patent_app_number] => 8/215906
[patent_app_country] => US
[patent_app_date] => 1994-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 20
[patent_no_of_words] => 4903
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/523/05523229.pdf
[firstpage_image] =>[orig_patent_app_number] => 215906
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/215906 | Antibodies specific for oncofetal fibronectin | Mar 21, 1994 | Issued |
Array
(
[id] => 3734397
[patent_doc_number] => 05753230
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Methods and compositions useful for inhibition of angiogenesis'
[patent_app_type] => 1
[patent_app_number] => 8/210715
[patent_app_country] => US
[patent_app_date] => 1994-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 35
[patent_no_of_words] => 19487
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753230.pdf
[firstpage_image] =>[orig_patent_app_number] => 210715
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/210715 | Methods and compositions useful for inhibition of angiogenesis | Mar 17, 1994 | Issued |